Transplantation and cellular therapy · 2022
Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kapadia Malika, Lehmann Leslie, Auletta Jeffery, Beatty Lisa, Bhatt Neel, Blacken Robyn, Demmel Kathy, Dodd Therese, Desmond Catherine, Fitch Taylor, Flesch Laura, Hartley David, Huber John, Ingraham Hannah, Jakubowski Rita, Klunk Anna, Krupski Christa, Kusnier Katilyn, Liberio Nicole, Maakaron Joseph, Mueller Mark, Myers Kasiani C, Pai Ahna, Parker Loretta, Patel Sagar, Phelan Rachel, Polishchuk Veronika, Sigmund Audrey, Sper Christine, Tarquini Sarah, Juckett Mark, Jaglowski Samantha, Dandoy Christopher, Rotz Seth
Аннотация
Quality improvement and quality assurance form a complementary and independent relationship. Quality assurance measures compliance against industry standards using audits, whereas quality improvement is a continuous process focused on processes and systems that can improve care. The Model for Improvement is a robust quality improvement tool that transplant and cellular therapy teams can use to redesign healthcare processes. The Model for Improvement uses several components addressed in sequence to organize and critically evaluate improvement activities. Unlike other health sciences clinical research, quality improvement projects, and research are based on dynamic hypotheses that develop into observable, serial tests of change with continuous collection and feedback of performance data to stakeholders.